Search - tctmd.com

Displaying 301 - 320 of 684

Sort: Relevancy | Date

News Daily News

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Michael O'Riordan

March 13, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Daily News

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Yael L. Maxwell

March 01, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

News Conference News ISC 2019

Durability of Surgery, Stenting for Symptomatic Carotid Stenosis Good for Up to a Decade

Todd Neale

February 11, 2019

News Daily News

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

L.A. McKeown

February 06, 2019

Presentation

Long-term Durability of Transcatheter Aortic Valve Prostheses

February 06, 2019

Presentation

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

February 06, 2019

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

L.A. McKeown

December 18, 2018

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

Global Investigative Journalism Initiative Takes Aim at Medical Device Industry

Todd Neale

November 26, 2018

News Conference News TCT 2018

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Todd Neale

September 26, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

Presentation TCT 2018

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presenter: Michael J. Mack, Bernard Prendergast, George D. Dangas

September 22, 2018

Presentation TCT 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presenter: Michael J. Mack, Bernard Prendergast, Davide Capodanno

September 22, 2018

Presentation TCT 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presenter: Michael J. Mack, Bernard Prendergast, Lars Sondergaard

September 22, 2018

Presentation TCT 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Adam B. Greenbaum

September 22, 2018

Presentation TCT 2018

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Adnan K. Chhatriwalla

September 22, 2018

Presentation TCT 2018

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Philipp Blanke

September 22, 2018

Presentation TCT 2018

Clinical Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Presenter: Michael J. Mack, Bernard Prendergast, John G. Webb

September 22, 2018

Advertisement

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Durability of Surgery, Stenting for Symptomatic Carotid Stenosis Good for Up to a Decade

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

Long-term Durability of Transcatheter Aortic Valve Prostheses

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Global Investigative Journalism Initiative Takes Aim at Medical Device Industry

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Clinical Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content